PBM · Psyence Biomedical Ltd.
$3.72
+0.24 (+6.90%)
At close · Aug 17
Market Cap
$13.27M
Shares
3.81M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-08-06 | — | |
| 20-F | 2026-06-22 | 2026-03-31 | |
| 6-K | 2026-06-05 | — | |
| 6-K | 2026-04-23 | — | |
| 6-K | 2026-04-20 | — | |
| 6-K | 2026-04-17 | — | |
| 6-K | 2026-04-15 | 2026-04-14 | |
| 6-K | 2026-03-02 | — | |
| 6-K | 2026-02-20 | 2026-02-19 | |
| 6-K | 2026-02-19 | — | |
| 6-K | 2026-02-13 | — | |
| 6-K | 2026-02-12 | — | |
| 6-K | 2026-01-29 | — | |
| 6-K | 2026-01-27 | — | |
| 6-K | 2026-01-14 | — | |
| 6-K | 2026-01-13 | — | |
| 6-K | 2026-01-08 | — | |
| 6-K | 2025-11-21 | — | |
| 6-K | 2025-11-20 | 2025-09-30 | |
| 6-K | 2025-11-10 | — | |
| 6-K | 2025-10-09 | — | |
| 6-K | 2025-09-05 | — | |
| 6-K | 2025-08-28 | — | |
| 6-K | 2025-06-25 | — | |
| 20-F | 2025-06-25 | 2025-03-31 | |
| 6-K | 2025-06-11 | — | |
| 6-K | 2025-05-20 | — | |
| 6-K | 2025-05-06 | — | |
| 6-K | 2025-04-23 | — | |
| 6-K | 2025-04-11 | — | |
| 6-K | 2025-04-01 | — | |
| 6-K | 2025-03-31 | — | |
| 6-K | 2025-01-23 | 2024-09-30 | |
| 6-K | 2024-12-31 | — | |
| 6-K | 2024-12-23 | — | |
| 6-K | 2024-12-19 | — | |
| 6-K | 2024-12-18 | — | |
| 6-K | 2024-12-04 | — | |
| 6-K | 2024-12-04 | — | |
| 6-K | 2024-12-03 | — | |
| 6-K | 2024-11-22 | — | |
| 6-K | 2024-11-12 | — | |
| 6-K | 2024-11-01 | — | |
| 6-K | 2024-10-23 | — | |
| 6-K | 2024-10-08 | — | |
| 6-K | 2024-09-20 | — | |
| 6-K | 2024-09-13 | — | |
| 6-K | 2024-09-05 | — | |
| 6-K | 2024-08-30 | — | |
| 6-K | 2024-08-20 | — |
Showing 1–50 of 60 filings